Source: hrreporter.com
‘May result in reduced access to medicines for Canadians’: Memo
By Andy Blatchford
Big pharma might cut R&D, delay new drugs if more generics with pharmacare
LOCATIONS WE SERVE: TORONTO, HAMILTON, LONDON, SUDBURY, OTTAWA, KINGSTON, MONTREAL, QUEBEC CITY, FREDERICTON, ST. JOHN'S, VANCOUVER, CALGARY, EDMONTON, REGINA, WINNIPEG
Leave a Reply